ClinicalTrials.gg
Not yet recruitingNCT07793591VETCKDUpdated Sep 3, 2026

Veteran Centered Meal Intervention in Chronic Kidney Disease

An interventional study of Medically tailored meals (MTMs) in Chronic Kidney Disease, sponsored by VA Office of Research and Development. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-09-03.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 22 studies in Renal Insufficiency, Chronic by VA Office of Research and Development — 5 open to participants now, 7 under way, none of them phase 3. Renal Insufficiency, Chronic · VA Office of Research and Development.

Planned enrollment
11th of 21
100 · median 100
Started
2027
the only one that year
No phase
10 of 22
3 open now
Registered
22nd of 22
by date

Among the 22 studies in Renal Insufficiency, Chronic by VA Office of Research and Development, this one is the 11th largest by planned enrollment of the 21 interventional ones that give a count, is the only one that started in 2027, is one of 10 with no phase, and was the 22nd registered.

Renal Insufficiency, Chronic

3,098 studies on the registry are indexed under Renal Insufficiency, Chronic; 700 are open to participants now.

Browse Renal Insufficiency, Chronic studies →

Open to participants now

5 of the 22 studies in Renal Insufficiency, Chronic by VA Office of Research and Development are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 434 Renal Insufficiency, Chronic studies recruiting now, 245 (56%) set no upper age limit and 110 (25%) stop at 75 or younger; 43 take children under 18; 80 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 22 studies in Renal Insufficiency, Chronic by VA Office of Research and Development, or all of them as a file.
02

Study summary

This study will study if medically tailored meals can improve health and well-being among Veterans with kidney disease. Participants will be randomly assigned to receive either medically tailored meals or usual care (wait-list control) for 3 months, followed by follow-up/crossover period. The study will evaluate blood pressure, kidney health, diet, quality of life, and other health outcomes, as well as the feasibility and acceptability of providing medically tailored meals to Veterans with kidney disease.

Read the detailed description

This pilot randomized clinical trial will evaluate the feasibility, acceptability, and preliminary effects of medically tailored meals among Veterans with chronic kidney disease. Approximately 100 Veterans with stage 3b or 4 chronic kidney disease and elevated systolic blood pressure will be enrolled and randomized 1:1 to receive medically tailored meals or usual care during an initial 3-month intervention period. Participants initially assigned to usual care will subsequently receive medically tailored meals during a 3-month crossover period. All participants will be followed for 6 months.

The medically tailored meal intervention will provide prepared meals designed to support dietary recommendations for chronic kidney disease and cardiovascular health. The study will assess intervention feasibility and acceptability, including recruitment, adherence, retention, completion of study assessments, and participant experiences with the meals.

Clinical outcomes will include systolic blood pressure, kidney function and injury measures, cardiometabolic laboratory markers, and vascular function. Dietary intake and diet quality will be assessed using 24-hour dietary recalls. Patient-reported and behavioral outcomes will include kidney disease-related quality of life, general health and well-being, treatment burden, and measures related to dietary behavior and self-management. Healthcare utilization and medication use will also be evaluated. Assessments will generally occur at baseline, 3 months, and 6 months.

03

Conditions studied

  • Chronic Kidney Disease

Keywords

  • medically tailored meals
  • chronic kidney disease
  • hypertension
  • nutrition
  • diet
  • Veterans
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Veteran enrolled in the Veterans Health Administration
  • Stage 3b or stage 4 Chronic Kidney Disease (CKD) ((estimated (eGFR) 15-44 milliliter (mL)/minute/1.73 square meter (m²))
  • Systolic blood pressure 140-160 mmHg (millimeters of mercury); with a ± 5 mmHg tolerance range
  • (BMI) between 18.5 and 40.0 kilogram (kg)/square meter (m²)
  • Able and willing to provide
  • Able and willing to participate in study visits and study procedures
  • Able to receive medically tailored meal deliveries within the study service area

Exclusion criteria

Exclusion Criteria:

  • Inability to communicate in English or severe hearing impairment either, preventing study participation
  • Participation in a medically tailored meal program within the previous 6 months
  • Diagnosis of heart failure
  • Major active gastrointestinal disorder that would interfere with participation or nutritional management
  • Active cancer treatment (chemotherapy) or anticipated treatment within the next 12 months
  • Pregnancy
  • Current homelessness preventing meal delivery
  • Active substance use disorder not in remission
  • Active psychosis or another condition that would impair participation
  • Terminal illness or less than 12 months
  • Any other medical, psychiatric, or social condition that, in the opinion of the investigators, would make participation unsafe or interfere with completion of the study
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

GFR and eGFR (kidney filtering)

GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².

Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Medically tailored meals

    Participants randomized to this arm will receive medically tailored meals for 3 months in addition to usual clinical care. Meals will be designed to support dietary recommendations for chronic kidney disease, kidney and cardiovascular health. Participants will also receive nutrition education and study-related dietary support.

    Other: Medically tailored meals (MTMs)

  • Other
    Wait-list control

    Participants randomized to this arm will continue usual clinical care without study-provided medically tailored meals during the initial 3-month randomized period. After completing the 3-month assessment, participants will cross over to receive the medically tailored meals intervention for 3 months.

    Other: Medically tailored meals (MTMs)

Interventions

  • OtherMedically tailored meals (MTMs)

    Medically tailored meals are prepared to support dietary recommendations for chronic kidney disease and cardiovascular health while considering individual dietary needs and preferences. The intervention also included nutrition education and study-related dietary support.

    Also known as: MTM

06

What researchers measure

Primary outcomes

  1. Systolic blood pressure (SBP)

    Change in systolic blood pressure (SBP), measured in mmHg, from baseline to the 3-month assessment.

    Time frame: 3 months

Secondary outcomes

  1. Urine albumin-to-creatinine ratio (UACR)

    Change in urine albumin-to-creatinine ratio (UACR; milligrams/gram) from baseline to 3 months, measured using urine laboratory testing through the VA clinical laboratory.

    Time frame: 3 months

  2. Estimated glomerular filtration rate (eGFR)

    Change in estimated glomerular filtration rate (eGFR; milliliter/minute/1.73\^square meter) from baseline to 3 months, based on serum creatinine OR cystatin C, measured through the VA clinical laboratory.

    Time frame: 3 months

Other outcomes

  1. Diet quality and intake

    Change in Healthy Eating Index score from baseline to 3 and 6 months, calculated from dietary nutrient intake assessed using the Automated Self-Administered 24-hour Dietary Assessment Tool (ASA24).

    Time frame: 3 months, 6 months

  2. Kidney Disease-Related Quality of Life

    Health-related quality of life will be assessed using the Kidney Disease Quality of Life-36 (KDQOL-36), a validated kidney disease-specific instrument. Results will be reported as KDQOL-36 scores, with higher scores indicating better health-related quality of life.

    Time frame: 3 months, 6 months

  3. Medically Tailored Meal Adherence

    Adherence to the medically tailored meal intervention will be assessed using structured weekly participant check-ins. Adherence will be calculated as the number of provided meals consumed divided by the number of meals provided, multiplied by 100, and reported as percent of meals consumed (%).

    Time frame: 3 months, 6 months

07

Study locations

1 site
08

References and documents

Publications

  • Perez LM, Ujano-De Motta L, Johnson-Koenke R, Jani A, Ikizler TA, Raghavan S, Leonard C, Jones CD. A Qualitative Study to Investigate the Nutrition Perspectives and Experiences of Veterans with CKD. Clin J Am Soc Nephrol. 2025 Nov 1;20(11):1503-1515. doi: 10.2215/CJN.0000000800. Epub 2025 Aug 8. PubMed 40779332 ↗
  • Perez L, Gendelman S, Kendrick J. Home-Delivered Medically Tailored Meal Engagement Among Hemodialysis Patients and Providers. J Ren Nutr. 2024 Jan;34(1):40-46. doi: 10.1053/j.jrn.2023.08.011. Epub 2023 Aug 26. PubMed 37640277 ↗
  • Perez LM, Biruete A, Wilund KR. Home-delivered meals as an adjuvant to improve volume overload and clinical outcomes in hemodialysis. Clin Kidney J. 2022 Apr 19;15(10):1829-1837. doi: 10.1093/ckj/sfac102. eCollection 2022 Oct. PubMed 36158146 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2027; primary completion for May 2030, 31 months later.

Of 580 non-industry interventional studies with no phase under Renal Insufficiency, Chronic, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 45. This study's planned 31 months is above that.

Counting every sponsor, half of 620 studies reached it within 23 months; a quarter within 10 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 18, 2026
First posted
Aug 28, 2026
StartEst.
Oct 1, 2027
Primary completionEst.
May 31, 2030
CompletionEst.
Aug 31, 2030
Last update
Sep 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07793591
Responsible party
Sponsor
First posted
Aug 28, 2026
Start date
Oct 1, 2027 (estimated)
Primary completion
May 31, 2030 (estimated)
Completion
Aug 31, 2030 (estimated)
Last update
Sep 3, 2026

Study contacts

Luis M Perez, PhD RD
Contact
luis.perez2@va.gov
(720) 467-0757
Maryam I Nuriyeva, MPH
Contact
Maryam.Nuriyeva@va.gov
(720) 857-2712
Luis M Perez, PhD RD
principal investigator · Rocky Mountain Regional VA Medical Center, Aurora, CO

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion